160 related articles for article (PubMed ID: 35945083)
41. Stereotactic Radiotherapy for Renal Cell Carcinoma: The Fallacy of (False) Positive Post-treatment Biopsy?
Correa RJM; Appu S; Siva S
Eur Urol; 2023 Sep; 84(3):287-288. PubMed ID: 37032187
[No Abstract] [Full Text] [Related]
42. Technique for stereotactic body radiotherapy for spinal metastases.
Foote M; Letourneau D; Hyde D; Massicotte E; Rampersaud R; Fehlings M; Fisher C; Lewis S; Macchia NL; Yu E; Laperriere NJ; Sahgal A
J Clin Neurosci; 2011 Feb; 18(2):276-9. PubMed ID: 21147535
[TBL] [Abstract][Full Text] [Related]
43. [A systematic review of radiotherapy for primary renal cell carcinoma].
Gladilina IA; Shabanov MA; Kushlinskii NE; Bliganov PI; Sergeev AN
Urologiia; 2022 Mar; (1):96-101. PubMed ID: 35274868
[TBL] [Abstract][Full Text] [Related]
44. Stereotactic Ablative Radiotherapy for ≥T1b Primary Renal Cell Carcinoma: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK).
Siva S; Correa RJM; Warner A; Staehler M; Ellis RJ; Ponsky L; Kaplan ID; Mahadevan A; Chu W; Gandhidasan S; Swaminath A; Onishi H; Teh BS; Lo SS; Muacevic A; Louie AV
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):941-949. PubMed ID: 32562838
[TBL] [Abstract][Full Text] [Related]
45. Chronic expanding hematoma of the left erector spinae muscle after stereotactic body radiotherapy for renal cell carcinoma: a case report.
Ishikawa Y; Yamamoto T; Umezawa R; Takahashi N; Takeda K; Suzuki Y; Jingu K
J Med Case Rep; 2022 Oct; 16(1):353. PubMed ID: 36184609
[TBL] [Abstract][Full Text] [Related]
46. Long term control and preservation of renal function after multiple courses of stereotactic body radiation therapy for renal cell carcinoma.
Reddy AV; Mills MN; Liauw SL; Baliga S; Kersh CR
Can J Urol; 2019 Apr; 26(2):9743-9745. PubMed ID: 31012841
[TBL] [Abstract][Full Text] [Related]
47. Stereotactic Body Radiotherapy for Large Primary Renal Cell Carcinoma.
Kaidar-Person O; Price A; Schreiber E; Zagar TM; Chen RC
Clin Genitourin Cancer; 2017 Oct; 15(5):e851-e854. PubMed ID: 28462856
[No Abstract] [Full Text] [Related]
48. The investigational role of cytoreductive stereotactic ablative radiation therapy (SABR) to the primary tumor in metastatic kidney cancer.
Ingrosso G; Lancia A; Festa E; Pisani AR; Bellavita R; Aristei C; Detti B
Expert Rev Anticancer Ther; 2024 Jul; 24(7):477-479. PubMed ID: 38682638
[No Abstract] [Full Text] [Related]
49. Solitary bone metastasis of renal cell carcinoma treated with limb-sparing surgery followed by radiotherapy.
Lavrenkov K; Meller I; Cohen Y
Isr Med Assoc J; 2002 May; 4(5):385-6. PubMed ID: 12040833
[No Abstract] [Full Text] [Related]
50. TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II.
Siva S; Chesson B; Bressel M; Pryor D; Higgs B; Reynolds HM; Hardcastle N; Montgomery R; Vanneste B; Khoo V; Ruben J; Lau E; Hofman MS; De Abreu Lourenco R; Sridharan S; Brook NR; Martin J; Lawrentschuk N; Kron T; Foroudi F
BMC Cancer; 2018 Oct; 18(1):1030. PubMed ID: 30352550
[TBL] [Abstract][Full Text] [Related]
51. Stereotactic radiotherapy for primary renal cell carcinoma: time for larger-scale prospective studies.
Pryor DI; Wood S
BJU Int; 2017 Nov; 120(5):603-604. PubMed ID: 29035017
[No Abstract] [Full Text] [Related]
52. Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?
Marvaso G; Corrao G; Oneta O; Pepa M; Zaffaroni M; Corso F; Gandini S; Cecconi A; Zerini D; Mazzola GC; Augugliaro M; Cossu Rocca M; Verri E; Cattani F; La Fauci F; Bergamaschi L; Luzzago S; Mistretta AF; Musi G; Nolè F; De Cobelli O; Orecchia R; Jereczek-Fossa BA
Clin Transl Oncol; 2021 Aug; 23(8):1717-1726. PubMed ID: 33687659
[TBL] [Abstract][Full Text] [Related]
53. Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer : Literature review and practice recommendations of the DEGRO Working Group on Stereotactic Radiotherapy.
Panje C; Andratschke N; Brunner TB; Niyazi M; Guckenberger M
Strahlenther Onkol; 2016 Dec; 192(12):875-885. PubMed ID: 27778052
[TBL] [Abstract][Full Text] [Related]
54. Hypofractionated stereotactic radiotherapy and radiosurgery for the treatment of patients with radioresistant brain metastases.
Scorsetti M; Facoetti A; Navarria P; Bignardi M; De Santis M; Ninone SA; Lattuada P; Urso G; Vigorito S; Mancosu P; Del Vecchio M
Anticancer Res; 2009 Oct; 29(10):4259-63. PubMed ID: 19846983
[TBL] [Abstract][Full Text] [Related]
55. Short communication: timeline of radiation-induced kidney function loss after stereotactic ablative body radiotherapy of renal cell carcinoma as evaluated by serial (99m)Tc-DMSA SPECT/CT.
Jackson P; Foroudi F; Pham D; Hofman MS; Hardcastle N; Callahan J; Kron T; Siva S
Radiat Oncol; 2014 Nov; 9():253. PubMed ID: 25424613
[TBL] [Abstract][Full Text] [Related]
56. Using Stereotactic Body Radiotherapy to Overcome the Radioresistant Reputation of Renal Cell Carcinoma.
Nguyen PL
Eur Urol Oncol; 2019 Sep; 2(5):524-525. PubMed ID: 31444135
[No Abstract] [Full Text] [Related]
57. Renal cell carcinoma treated with stereotactic radiotherapy with histological change confirmed on autopsy: a case report.
Onishi H; Kawasaki T; Zakoji H; Yoshida T; Komiyama T; Kuriyama K; Araya M; Saito R; Aoki S; Maehata Y; Tominaga L; Marino K; Watanabe I; Oguri M; Araki T; Enomoto N; Takeda M; Katoh R
BMC Res Notes; 2014 Apr; 7():270. PubMed ID: 24767701
[TBL] [Abstract][Full Text] [Related]
58. Stereotactic body radiotherapy for primary renal cell carcinoma and adrenal metastases.
Kothari G; Louie AV; Pryor D; Vela I; Lo SS; Teh BS; Siva S
Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S17. PubMed ID: 28917255
[TBL] [Abstract][Full Text] [Related]
59. Treatment of brain metastases in renal cell carcinoma: radiotherapy, radiosurgery, or surgery?
Muacevic A; Siebels M; Tonn JC; Wowra B
World J Urol; 2005 Jul; 23(3):180-4. PubMed ID: 15791468
[TBL] [Abstract][Full Text] [Related]
60. Radiotherapy for brain metastases from renal cell cancer: should whole-brain radiotherapy be added to stereotactic radiosurgery?: analysis of 88 patients.
Fokas E; Henzel M; Hamm K; Surber G; Kleinert G; Engenhart-Cabillic R
Strahlenther Onkol; 2010 Apr; 186(4):210-7. PubMed ID: 20165820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
